147 related articles for article (PubMed ID: 38029748)
1. Management of Bivalirudin Dosing and Replacement Fluid During Therapeutic Plasma Exchange in Children on Extracorporeal Membrane Oxygenation.
Chomat MR; Swanson K; Barton K; Douds M; Said AS
ASAIO J; 2024 Mar; 70(3):e31-e37. PubMed ID: 38029748
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
[TBL] [Abstract][Full Text] [Related]
3. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
[TBL] [Abstract][Full Text] [Related]
4. Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
Campbell CT; Diaz L; Kelly B
Ann Pharmacother; 2021 Jan; 55(1):59-64. PubMed ID: 32590908
[TBL] [Abstract][Full Text] [Related]
5. Is anticoagulation with bivalirudin comparable to heparin for pediatric extracorporeal life support? Results from a high-volume center.
Schill MR; Douds MT; Burns EL; Lahart MA; Said AS; Abarbanell AM
Artif Organs; 2021 Jan; 45(1):15-21. PubMed ID: 32557733
[TBL] [Abstract][Full Text] [Related]
6. Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation.
Buckley MS; Benanti GE; Meckel J; Tekle LA; Gilbert B; Puebla Neira D; McNierney DA; Korkames G; Yerondopoulos M; Park A; O'Hea JA; MacLaren R
Pharmacotherapy; 2023 Mar; 43(3):196-204. PubMed ID: 36759323
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin.
Kartika T; Mathews R; Migneco G; Bundy T; Kaempf AJ; Pfeffer M; DeLoughery TG; Moore K; Beardshear R; Oetken HJ; Case J; Hinds MT; McCarty OJT; Shatzel JJ; Zonies D; Zakhary B
Eur J Haematol; 2024 Apr; 112(4):566-576. PubMed ID: 38088062
[TBL] [Abstract][Full Text] [Related]
8. Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.
Huang D; Guan Q; Qin J; Shan R; Wu J; Zhang C
Perfusion; 2023 Sep; 38(6):1133-1141. PubMed ID: 35616224
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Bivalirudin Versus Unfractionated Heparin for Anticoagulation in Adult Patients on Extracorporeal Membrane Oxygenation.
Sheridan EA; Sekela ME; Pandya KA; Schadler A; Ather A
ASAIO J; 2022 Jul; 68(7):920-924. PubMed ID: 34669620
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
Hanna DJ; Torbic H; Militello M; Strnad K; Krishnan S; Hohlfelder B
Int J Artif Organs; 2022 Aug; 45(8):688-694. PubMed ID: 35708334
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
[TBL] [Abstract][Full Text] [Related]
12. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.
Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM
ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942
[TBL] [Abstract][Full Text] [Related]
14. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
15. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure.
Bissell BD; Gabbard T; Sheridan EA; Baz MA; Davis GA; Ather A
Ann Pharmacother; 2022 Apr; 56(4):387-392. PubMed ID: 34323121
[TBL] [Abstract][Full Text] [Related]
17. Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis.
Liu L; Liu F; Tan J; Zhao L
Pharmacol Res; 2022 Mar; 177():106089. PubMed ID: 35065202
[TBL] [Abstract][Full Text] [Related]
18. Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.
Wieruszewski PM; Macielak SA; Nei SD; Moman RN; Seelhammer TG; Nabzdyk CGS; Gerberi DJ; Mara KC; Hooten WM; Wittwer ED
ASAIO J; 2023 Feb; 69(2):137-144. PubMed ID: 36355803
[TBL] [Abstract][Full Text] [Related]
19. Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19.
Seelhammer TG; Rowse P; Yalamuri S
J Cardiothorac Vasc Anesth; 2021 Apr; 35(4):1149-1153. PubMed ID: 32660924
[TBL] [Abstract][Full Text] [Related]
20. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.
Li DH; Sun MW; Zhang JC; Zhang C; Deng L; Jiang H
Thromb Res; 2022 Feb; 210():53-62. PubMed ID: 35007937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
